anti-cd123 (R&D Systems)
Structured Review
Anti Cd123, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/301-R3/Recombinant+Human+IL-3R+alpha%2FCD123+Protein%2C+CF/pmc11772844-163-4-13
Average 93 stars, based on 2 article reviews
Images
Related Articles
other:Article Title: A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins. Article Snippet: For generation of monoclonal anti-CD123 antibodies, Article Title: A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins Article Snippet: For generation of monoclonal anti-CD123 antibodies, Article Title: A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins Article Snippet: To detect free (unbound) antibody in solution using the (ECLIA) assay, MSD SA-STD plates were blocked with 50 μL per well of assay buffer (PBS containing 0.2% BSA, 0.05% Tween 20) for at least 5 min. Plates were turned over to remove assay buffer and tapped on paper towels and 50 μL per well of 0.7 μg/mL Recombinant:Article Title: A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins Article Snippet: For generation of monoclonal anti-CD3 antibodies, monoclonal antibody SP34, mouse IgG3/lambda isotype (BD Biosciences, Pharmingen, 556,611) and monoclonal antibody, SP34-2, mouse IgG1/lambda isotype (BD Biosciences, Pharmingen, 551,916) were purchased. .. Article Title: A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins Article Snippet: .. Following antibody capture, Injection:Article Title: A novel label-free method to determine equilibrium dissociation constants of antibodies binding to cell surface proteins Article Snippet: .. Following antibody capture, |
